The problem with ampoules.
Ampoule products in the business of AAS are usually a marketing ploy. Especially for European users, ampoules look more professional and more often than not are sold for a disproportionally higher price than the 10ml variants. Manufacturers use the exact same procedures and excipients with the only difference the addition of a cheap (usually Chinese made) ampoule filling and sealing machine.
The problem with machines like that is that they are copies of American or European 1970s era machines, because they are copies and usually poorly made, tolerances, surface porosity, lubricants and built quality are poor causing the user to be constantly monitoring and servicing a procedure that should be fairly automatised.
The benefits of Ampoules.
On the other hand ampoules can have immense benefits for the AAS user if are done correctly. The ampoule is by definition hermetically sealed and single use, this allows the manufacturer to do a terminal sterilisation. The product is sterilised via dry heat after its sealed, this means that until it is open it is completely free of any contamination.
As a result no bacteriostatic agents like benzyl alcohol are used. Additionally the fact that the ampoule is a homogenous material, unlike the 10ml which has a rubber stopper means that ethyl oleate can be used without fear of dissolving the rubber stopper even after long term storage in non ideal temperatures.
Those two facts combine give a significant benefit for the advanced user. The fact that the solution is made with less solvents and using carrier oils that are both less viscous and less irritating to the tissues means that users that need either frequent or voluminous administrations of AAS dont have to worry about scar tissue formation.
How we do it
We take pride in the fact that we can adapt, improvise and overcome problems that would make impossible or bog down less experienced manufacturers. Our ampoule manufacturing procedure follows as closely as possible European procedural sterility and manufacturing guidelines with a few changes that bring costs down to manageable both for us and the buyer.
(Pictures of the machine or more information will not be disclosed because there are very few in the world.)
We acquired an American made filling and sealing machine with an original cost in the low six digits that was operated by the Research and Development department of a very well know pharmaceutical company. The machine was completely refurbished with constant communication and feedback from the original designer, parts that where not available where CNC machined from A316 stainless steel, lubricants used are H1 food grade.
The same process of aseptic production is used and terminal sterilisation is performed in a memmert SN30plus Sterilising oven, 160c for 90 minutes. Aqueous solutions like stanozolol are terminal sterilised at 120 for 2 hours in an overpressure environment to avoid failure of the ampoule glass.
Understandably those extra steps require time, effort, technical knowhow and equipment and that means a somewhat higher price. We do keep that to a minimum and our premium line products are priced only according to the costs without any extra overhead profit just because “it looks better”.
With regards the Advar team.